Surmodics, Inc. (SRDX) Social Stream
SURMODICS INC (SRDX) Price Targets From Analysts
Use the tables below to see what analysts covering SURMODICS INC think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
Price Target Last Issued September 15, 2022
The Trend in the Analyst Price Target
Over the past 16 months, SRDX's average price target has gone down $4.25.
Over the past 51 weeks, SRDX's average upside potential has been 75.36%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
SRDX Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
SRDX's average broker recommendation rating improved by 0.5 over the prior 30 weeks.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- SRDX has a higher number of analysts covering the stock than 7.98% of all US stocks.
- SURMODICS INC's variance in analysts' estimates is lower than 91.91% of all US stocks.
- SURMODICS INC's average analyst price target is higher than 287.68% of stocks in the small market cap category.
- SURMODICS INC's upside potential (average analyst target price relative to current price) is greater than 197.66% of Medical Equipment stocks.
Make investment decisions regarding SRDX using the data that counts. Try POWR Ratings for free.